Skip to main content
SAMSUNG PHARMACEUTICAL.CO.,Ltd. logo

SAMSUNG PHARMACEUTICAL.CO.,Ltd. — Investor Relations & Filings

Ticker · 001360 ISIN · KR7001360007 KO Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2023-11-17 Capital/Financing Update
Country KR South Korea
Listing KO 001360

About SAMSUNG PHARMACEUTICAL.CO.,Ltd.

http://www.sspharm.com/

Samsung Pharmaceutical Co., Ltd. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products. Its portfolio includes a range of medications, such as antibiotics and liver treatments, with a research focus on therapeutic areas like neoplasms. In addition to its core pharmaceutical operations, the company is also involved in the bio business and the sale of health foods.

Recent filings

Filing Released Lang Actions
증권신고서(지분증권) (2024.01)
Capital/Financing Update Classification · 100% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) of South Korea. It details a capital increase (유상증자) through a rights offering followed by a public offering of unsubscribed shares. This document is a formal regulatory filing required for public offerings of securities, which falls under the category of capital and financing updates.
2023-11-17 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Samsung Pharm, covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial information, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding (a lawsuit for damages) filed against Samsung Pharmaceutical. It details the case name, the plaintiff, the claim amount, and the company's response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant litigation involving the company.
2023-09-05 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Samsung Pharm, covering the period from January 1, 2023, to June 30, 2023. It contains detailed company information, business operations, financial data, and management discussions. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-14 Korean
투자판단관련주요경영사항(알츠하이머병 치료제로서 GV 1001의 국내 제3상 임상시험계획 변경 승인)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Samsung Pharmaceutical regarding a material management decision (major business matter) concerning the approval of a clinical trial plan change for an Alzheimer's drug (GV1001). It is filed through the Korean Exchange (KRX) system (KIND). Since it details a specific regulatory event (clinical trial approval) and does not fit into categories like financial reports, dividends, or director dealings, it is classified as a general regulatory filing.
2023-06-23 Korean
투자판단관련주요경영사항(알츠하이머병 치료제로서 GV 1001의 국내 제3상 임상시험계획 변경 승인신청)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure from Samsung Pharmaceutical regarding a change in the sponsor for a Phase 3 clinical trial of the drug GV1001. It is filed as a 'Major Management Matter' (투자판단 관련 주요경영사항), which is a standard regulatory filing format in Korea for material corporate events. Since it does not fit into specific categories like financial reports, dividends, or board changes, and is a formal regulatory announcement of a material event, it is classified as a Regulatory Filing (RNS).
2023-06-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.